Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕Edelweiss Recently Listed IPO Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaEdelweiss
NAV₹666.3420₹36.4592
NAV date20 Nov 202620 Nov 2026
History13.9 years8.7 years
Expense ratio1.0%1.4%
Stars★★★★★★★★★★
Growth Score75.2045.20

Returns

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
1 month+11.40%+5.92%
3 months+3.74%+2.40%
6 months+8.55%+20.35%
YTD+16.94%+25.20%
1 year+15.26%+23.75%
3 years (CAGR)+17.96%+17.13%
5 years (CAGR)+15.40%+11.04%
10 years (CAGR)+16.61%—
Since launch+17.63%+15.95%

Risk

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
Volatility14.1%20.9%
Downside volatility9.0%12.9%
Sharpe0.810.51
Sortino1.280.82
Calmar1.220.69
Return / risk1.270.82
Deepest fall−24.02%−32.34%
Days to recover445155
Below its high+0.00%−1.63%

Against benchmark

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
Alpha−1.86%+5.69%
Beta0.890.97
R²89.5%56.3%
Up capture85.2%114.2%
Down capture88.7%93.5%
Tracking error4.8%13.8%
Information ratio−0.690.40
Treynor0.120.10

Consistency

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
Best 1-year+90.70%+98.01%
Middle 1-year+13.13%+17.30%
Worst 1-year−15.12%−23.25%
1-year periods with a loss23.2%23.7%
Middle 3-year+19.82%+18.97%
Positive months63.9%66.7%
Best day+3.40%+3.68%
Worst day−3.21%−5.79%
Worst 5% day−1.38%−1.93%
Positive days53.7%57.6%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
5-year XIRR+18.24%+17.87%
5-year value₹9,54,076₹9,45,521
3-year XIRR+14.26%+18.35%
1-year XIRR+22.08%+35.31%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth